Lipid abnormalities in HIV-infected patients are not correlated with lopinavir plasma concentrations

被引：15
|
作者：
Torti, C [1 ]
Quiros-Roldan, E
Regazzi-Bonora, M
De Luca, A
Lo Caputo, S
Di Giambenedetto, S
Patroni, A
Villani, P
Micheli, V
Carosi, G
机构：
[1] Univ Brescia, Inst Infect & Trop Med, Brescia, Italy
[2] Policlin San Matteo, IRCCS, Serv Clin Pharmacol, Pavia, Italy
[3] Univ Cattolica Sacro Cuore, Inst Infect Dis, Rome, Italy
[4] AM Annunziata Hosp, ASL Firenze, Florence, Italy
[5] L Sacco Hosp Vialba, Dept Infect Dis, Milan, Italy
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2004年 / 35卷 / 03期
关键词：
D O I：
10.1097/00126334-200403010-00017
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：324 / 326
页数：3
相关论文
共 50 条
  • [1] Lipid abnormalities in HIV-infected patients and lopinavir plasma concentrations
    Gutiérrez, F
    Padilla, S
    Navarro, A
    Masiá, M
    Hernández, I
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (05) : 1107 - 1109
  • [2] High lopinavir plasma concentrations are associated with changes in lipid levels at m6 in HIV-infected patients
    Besnier, JM
    Veillon, S
    Arsac, P
    Guimard, Y
    Bourgoin, H
    Bastides, F
    Garot, D
    Autret-Leca, E
    Choutet, P
    Le Guellec, C
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S221 - S221
  • [3] Association of lopinavir concentrations with plasma lipid or glucose concentrations in HIV-infected South Africans: a cross sectional study
    Phumla Z Sinxadi
    Helen M McIlleron
    Joel A Dave
    Peter J Smith
    Naomi S Levitt
    Gary Maartens
    AIDS Research and Therapy, 9
  • [4] Association of lopinavir concentrations with plasma lipid or glucose concentrations in HIV-infected South Africans: a cross sectional study
    Sinxadi, Phumla Z.
    McIlleron, Helen M.
    Dave, Joel A.
    Smith, Peter J.
    Levitt, Naomi S.
    Maartens, Gary
    AIDS RESEARCH AND THERAPY, 2012, 9
  • [5] Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patients
    Seminari, E
    Gentilini, G
    Galli, L
    Hasson, H
    Danise, A
    Carini, E
    Dorigatti, F
    Soldarini, A
    Lazzarin, A
    Castagna, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (04) : 790 - 792
  • [6] Characterization of lipid abnormalities occurring in HIV-infected individuals on Kaletra (Lopinavir/ritonavir, KLT)
    Aberg, JA
    Juenther, S
    Prelutsky, D
    Royal, M
    Parks, D
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1203 - 1203
  • [7] Trough Lopinavir Concentrations in Preterm HIV-infected Infants
    Holgate, Sandi L.
    Rabie, Helena
    Smith, Peter
    Cotton, Mark F.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (06) : 602 - 604
  • [8] Lopinavir concentrations are not associated with increased plasma lipid or glucose concentrations in HIV infected South Africans
    Sinxadi, P. Z.
    McIlleron, H. M.
    Dave, J. A.
    Smith, P. J.
    Levitt, Naomi S.
    Maartens, G.
    ANTIVIRAL THERAPY, 2010, 15 : A61 - A61
  • [9] Lopinavir concentrations are not associated with increased plasma lipid or glucose concentrations in HIV infected South Africans
    Sinxadi, P. Z.
    McIlleron, H. M.
    Dave, J. A.
    Smith, P. J.
    Levitt, Naomi S.
    Maartens, G.
    ANTIVIRAL THERAPY, 2010, 15 (08) : A61 - A61
  • [10] An enzyme immunoassay for the quantification of plasma and intracellular lopinavir in HIV-infected patients
    Azoulay, S
    Nevers, MC
    Créminon, C
    Heripret, L
    Garraffo, R
    Durant, J
    Dellamonica, P
    Grassi, J
    Guedj, R
    Duval, D
    JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 295 (1-2) : 37 - 48
12345